Journal profile · Clinical Neurology
Neuromuscular Disorders
ISSN 0960-8966 · eISSN 1873-2364 · Elsevier Ltd · UNITED STATES · Monthly · Founded 1991
Neuromuscular Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.29; hybrid open access; APC about USD 3,470; median 101 days to acceptance (102 articles, last 24 months); community-reported acceptance: fairly easy; 912 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neuromuscular Disorders is published by Elsevier Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Muscle Physiology and Disorders, Neurogenetic and Muscular Disorders Research and Genetic Neurodegenerative Diseases, together about 44.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Neuromuscular Disorders is the official Journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.The journal is a platform for clinical academics and scientists to publish their research results from studies on neuromuscular diseases including acquired and hereditary diseases that affect the muscle, the neuromuscular junction or the lower motor neuron.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology24.3%
- Neurogenetic and Muscular Disorders ResearchMedicine12.1%
- Genetic Neurodegenerative DiseasesNeuroscience8.2%
- Cardiomyopathy and Myosin StudiesMedicine7.6%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology4.5%
- Inflammatory Myopathies and DermatomyositisMedicine4.2%
- Myasthenia Gravis and ThymomaMedicine3.2%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.29LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- CiteScore (publisher)
- 4.6Publisher website ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 0.93LetPub ·
- h-index
- 89LetPub ·
- h-index
- 140OpenAlex ·
- i10-index
- 2,995OpenAlex ·
- 2-year mean citedness
- 0.36OpenAlex ·
- Self-citation rate
- 5.7%LetPub ·
- Share of gold OA articles
- 28.26%LetPub ·
Volume
- Articles per year
- 98LetPub ·
Articles by year OpenAlex count · 16,920 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,008 | 59 | 35 |
| 2025 | 912 | 81 | 326 |
| 2024 | 961 | 82 | 663 |
| 2023 | 677 | 112 | 1,401 |
| 2022 | 558 | 105 | 1,521 |
| 2021 | 594 | 119 | 2,662 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
101 daysMedian, submission to acceptance · P25–P75 63 days – 135 days
- Acceptance to online
- median 1 days (102 articles)
- Submission to online
- median 103 days
- Sample
- 102 articles with submission and acceptance dates (238 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 48 daysPublisher website ·
- Submission to acceptance
- 93 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,470 / EUR 3,250 / GBP 2,780 / JPY 430,380 | — | — | |
| Publisher website | USD 3,620 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 3,620 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1991
- ISSN
- 0960-8966
- Electronic ISSN
- 1873-2364
- Society / sponsor
- World Muscle Society an international
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Neuromuscular Disorders
What CAS zone is Neuromuscular Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neuromuscular Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuromuscular Disorders?
The latest impact factor listed by LetPub is 3.29; CiteScore 4.6, h-index 140.
How long does peer review take at Neuromuscular Disorders?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 63–135 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Neuromuscular Disorders?
According to LetPub and DOAJ records, Neuromuscular Disorders is indexed in SCIE and Scopus.
Is Neuromuscular Disorders open access, and what is the APC?
Neuromuscular Disorders is a hybrid journal. For open-access publication: APC about USD 3,470.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .